Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva

En éste documento se detallan las indicaciones básicas a seguir para la presentación de trabajos de investigación al XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo”

Autores:
Rueda Espinel, Santiago
Tipo de recurso:
http://purl.org/coar/resource_type/c_f744
Fecha de publicación:
2021
Institución:
Universidad Autónoma de Bucaramanga - UNAB
Repositorio:
Repositorio UNAB
Idioma:
spa
OAI Identifier:
oai:repository.unab.edu.co:20.500.12749/20369
Acceso en línea:
http://hdl.handle.net/20.500.12749/20369
Palabra clave:
Gynecology
Obstetrics
Abortion
Investigation
Misoprostol
Maternal mortality
Pregnancy
Women
Ginecología
Obstetricia
Aborto
Investigación
Misoprostol
Mortalidad materna
Embarazo
Mujeres
Rights
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UNAB2_9e67ca563a14b97441f5981b728b6d34
oai_identifier_str oai:repository.unab.edu.co:20.500.12749/20369
network_acronym_str UNAB2
network_name_str Repositorio UNAB
repository_id_str
dc.title.spa.fl_str_mv Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
dc.title.translated.spa.fl_str_mv Factors associated with the success of medical management with misoprostol in spontaneous abortion: a prospective cohort
title Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
spellingShingle Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
Gynecology
Obstetrics
Abortion
Investigation
Misoprostol
Maternal mortality
Pregnancy
Women
Ginecología
Obstetricia
Aborto
Investigación
Misoprostol
Mortalidad materna
Embarazo
Mujeres
title_short Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
title_full Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
title_fullStr Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
title_full_unstemmed Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
title_sort Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva
dc.creator.fl_str_mv Rueda Espinel, Santiago
dc.contributor.author.none.fl_str_mv Rueda Espinel, Santiago
dc.contributor.cvlac.spa.fl_str_mv Rueda Espinel, Santiago [0000037531]
dc.contributor.orcid.spa.fl_str_mv Rueda Espinel, Santiago [0000-0003-2156-166X]
dc.contributor.researchgroup.spa.fl_str_mv Semilleros de Investigación UNAB
dc.subject.keywords.spa.fl_str_mv Gynecology
Obstetrics
Abortion
Investigation
Misoprostol
Maternal mortality
Pregnancy
Women
topic Gynecology
Obstetrics
Abortion
Investigation
Misoprostol
Maternal mortality
Pregnancy
Women
Ginecología
Obstetricia
Aborto
Investigación
Misoprostol
Mortalidad materna
Embarazo
Mujeres
dc.subject.lemb.spa.fl_str_mv Ginecología
Obstetricia
Aborto
Investigación
dc.subject.proposal.spa.fl_str_mv Misoprostol
Mortalidad materna
Embarazo
Mujeres
description En éste documento se detallan las indicaciones básicas a seguir para la presentación de trabajos de investigación al XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo”
publishDate 2021
dc.date.issued.none.fl_str_mv 2021-11
dc.date.accessioned.none.fl_str_mv 2023-06-28T23:11:34Z
dc.date.available.none.fl_str_mv 2023-06-28T23:11:34Z
dc.type.eng.fl_str_mv Conference
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/conferenceProceedings
dc.type.local.spa.fl_str_mv Memoria de eventos
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_f744
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/acceptedVersion
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/EC_AC
format http://purl.org/coar/resource_type/c_f744
status_str acceptedVersion
dc.identifier.issn.spa.fl_str_mv ISSN 2344-7079
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12749/20369
dc.identifier.instname.spa.fl_str_mv instname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional UNAB
dc.identifier.repourl.spa.fl_str_mv repourl:https://repository.unab.edu.co
identifier_str_mv ISSN 2344-7079
instname:Universidad Autónoma de Bucaramanga - UNAB
reponame:Repositorio Institucional UNAB
repourl:https://repository.unab.edu.co
url http://hdl.handle.net/20.500.12749/20369
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.ispartofseries.spa.fl_str_mv Generación Creativa : Encuentro de Semilleros de Investigación UNAB
dc.relation.uri.spa.fl_str_mv http://hdl.handle.net/20.500.12749/20335
dc.relation.references.spa.fl_str_mv [1] Peña García MJ. Guía de Práctica Clínica (GPC) para el manejo médico del aborto en el Hospital Local del Norte - E.S.E ISABU. 2018;
[2] Organización Mundial de la Salud. Mortalidad materna. 2018;Nota descriptiva No. 348.
[3] Sur SD, Raine-Fenning NJ. The management of miscarriage. Best Pract Res Clin Obstet Gynaecol. Elsevier Ltd. 2009;23(4):479–91.
[4] Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynecol Obstet. 2007;99:186–9.
[5] Creinin MD, Barnhart K, Zhang J, Gilles JM, Westhoff C, Huang X. Factors Related to Successful Misoprostol Treatment for Early Pregnancy Failure. Obstet Gynecol. 2006;107(4):901–7.
[6] Barceló F, De Paco C, López-Espín JJ, Silva Y, Abad L, Parrilla JJ. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol. Aust New Zeal J Obstet Gynaecol. 2012;52(1):39–43.
[7] Committee on Practice Bulletins—Gynecology. Early Pregnancy Loss. Am Coll Obstet Gynecol [Internet]. 2015; number 150. Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Practice- Bulletins/Committee-on-Practice-Bulletins-Gynecology/Early-Pregnancy-Loss
[8] Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first- trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860–7.
[9] Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynecol Obstet. 2007;99:172–7.
[10] Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004;19(2):266–71.
[11] INVIMA. Mifepristona [Internet]. Expediente 20104433. 2016. Available from: http://consultaregistro.invima.gov.co:8082/Consultas/consultas/consreg_encabcum.jsp
[12] von Hertzen H, Piaggio G, Huong NTM, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet. 2007;369(9577):1938–46.
[13] Tang OS, Ho PC. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion. Contraception. 2006;74(1):26–30.
[14] Committee on Practice Bulletins—Gynecology and the Society of Family Planning. Medical management of first-trimester abortion. Am Coll Obstet Gynecol. 2014;89(3):148–161.
[15] Tang J, Kapp N, Dragoman M, De Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynecol Obstet [Internet]. 2013;121(2):186–9. Available from: http://dx.doi.org/10.1016/j.ijgo.2012.12.009
[16] Jp N, Gml G, Hickey M, Jc V, Dou L. Medical treatments for incomplete miscarriage (Review). Cochrane Libr. 2013;(3).
[17] Gómez-Sánchez P. Manual FLASOG uso Misoprostol en Ginecoobstetricia. 2013.
[18] INVIMA. Acta 20, Radicado 7023192. Minist Salud y Protección Soc. 2007.
[19] Corte Constitucional. Sentencia C-355/06 [Internet]. República de Colombia. 2006. Available from: http://www.corteconstitucional.gov.co/relatoria/2006/c-355-06.htm
[20] INVIMA. Decreto No. 4444. 2005.
[21] Colombia Ministerio de la Protección Social. Resolución 4905 [Internet]. 2006. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución 4905 de 2006.PDF
[22] Blanchard K, Shochet T, Coyaji K, Nguyen Thi NN, Winikoff B. Misoprostol alone for early abortion: An evaluation of seven potential regimens. Contraception. 2005;72(2):91–7.
[23] Gemzell-Danielsson K, Bygdeman M, Aronsson A. Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006;74(1):31–5.
[24] Gemzell-Danielsson, L Marions, A Rodriguez, BW Spur, PYK Wong MB. Comparison Between Oral and Vaginal Administration of Misoprostol on Uterine Contractility. Am Coll Obstet Gynecol Elsevier. 1999;93(2):275–80.
[25] Granstrom G, Granstrom M, Anderson M. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone mifepristone and an exogenous prostaglandin given. Lancet. 1991;338:1233–6.
[26] Odeh M, Tendler R, Kais M, Maximovsky O, Ophir E, Bornstein J. Early pregnancy failure: Factors affecting successful medical treatment. Isr Med Assoc J. 2010;12(6):325–8.
[27] Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, et al. Outcome of first trimester medical termination of pregnancy: definitions and management. Eur J Contracept Reprod Heal Care [Internet]. 2018;23(6):451–7. Available from: https://doi.org/10.1080/13625187.2018.1535058
[28] Chung T, Leung P, Cheung L, Haines C, Chang A. A medical approach to management of spontaneous abortion using misoprostol. Acta Obstet Gynecol Scand. 1997;76:248–51.
[29] Cheung LP, Haines CJ, Chang AMZ. Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril. 1999;71(6):1054–9.
[30] Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception [Internet]. 2016;94(2):97–103. Available from: http://dx.doi.org/10.1016/j.contraception.2016.04.013
[31] Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynecol Obstet. 2017;138(3):363–6.
[32] Berghella V, Airoldi J, O’Neill A, Einhorn K, Hoffman M. Misoprostol for second trimester pregnancy termination in women with prior caesarean: A systematic review. BJOG An Int J Obstet Gynaecol. 2009;116(9):1151–7.
[33] Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: A systematic review. Am Coll Obstet Gynecol. 2009;113(5):1117–23.
[34] Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Westhoff C, et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. Am J Obstet Gynecol. 2008;198(6):626.e1-626.e5.
[35] Memtsa M, Jauniaux E, Gulbis B, Nyrhinen NC, Jurkovic D. Maternal serum markers in predicting successful outcome in expectant management of missed miscarriage. Reprod Biomed Online, Elsevier [Internet]. 2017;34(1):98–103. Available from: http://dx.doi.org/10.1016/j.rbmo.2016.09.004
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.local.spa.fl_str_mv Abierto (Texto Completo)
dc.rights.creativecommons.*.fl_str_mv Atribución-NoComercial-SinDerivadas 2.5 Colombia
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Abierto (Texto Completo)
Atribución-NoComercial-SinDerivadas 2.5 Colombia
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.coverage.spatial.spa.fl_str_mv Bucaramanga (Santander, Colombia)
dc.coverage.temporal.spa.fl_str_mv 2021
dc.coverage.campus.spa.fl_str_mv UNAB Campus Bucaramanga
dc.publisher.grantor.spa.fl_str_mv Universidad Autónoma de Bucaramanga UNAB
dc.publisher.faculty.spa.fl_str_mv Facultad Ciencias de la Salud
dc.publisher.deparment.spa.fl_str_mv Sistema de Investigación SIUNAB
dc.source.spa.fl_str_mv Rueda, S. (2021). Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva. Recuperado de: http://hdl.handle.net/20.500.12749/20369.
institution Universidad Autónoma de Bucaramanga - UNAB
bitstream.url.fl_str_mv https://repository.unab.edu.co/bitstream/20.500.12749/20369/1/2021_Articulo_Rueda_Espinel_Santiago.pdf
https://repository.unab.edu.co/bitstream/20.500.12749/20369/2/license.txt
https://repository.unab.edu.co/bitstream/20.500.12749/20369/3/2021_Articulo_Rueda_Espinel_Santiago.pdf.jpg
bitstream.checksum.fl_str_mv e86a5908412ff9c7377ad6dcc926afe8
3755c0cfdb77e29f2b9125d7a45dd316
8b393d30c42f219fade49dfcf64d4d41
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional | Universidad Autónoma de Bucaramanga - UNAB
repository.mail.fl_str_mv repositorio@unab.edu.co
_version_ 1814277287808335872
spelling Rueda Espinel, Santiago50a0ae21-9bd5-4c81-8bc2-8fe702c73bdbRueda Espinel, Santiago [0000037531]Rueda Espinel, Santiago [0000-0003-2156-166X]Semilleros de Investigación UNABBucaramanga (Santander, Colombia)2021UNAB Campus Bucaramanga2023-06-28T23:11:34Z2023-06-28T23:11:34Z2021-11ISSN 2344-7079http://hdl.handle.net/20.500.12749/20369instname:Universidad Autónoma de Bucaramanga - UNABreponame:Repositorio Institucional UNABrepourl:https://repository.unab.edu.coEn éste documento se detallan las indicaciones básicas a seguir para la presentación de trabajos de investigación al XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo”In this paper, we describe the formatting guidelines for the XII Encuentro de Semilleros de Investigación “El Intercambio del Conocimiento: Base para el Desarrollo". The abstract most be written in english.Modalidad Presencialapplication/pdfspaGeneración Creativa : Encuentro de Semilleros de Investigación UNABhttp://hdl.handle.net/20.500.12749/20335[1] Peña García MJ. Guía de Práctica Clínica (GPC) para el manejo médico del aborto en el Hospital Local del Norte - E.S.E ISABU. 2018;[2] Organización Mundial de la Salud. Mortalidad materna. 2018;Nota descriptiva No. 348.[3] Sur SD, Raine-Fenning NJ. The management of miscarriage. Best Pract Res Clin Obstet Gynaecol. Elsevier Ltd. 2009;23(4):479–91.[4] Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynecol Obstet. 2007;99:186–9.[5] Creinin MD, Barnhart K, Zhang J, Gilles JM, Westhoff C, Huang X. Factors Related to Successful Misoprostol Treatment for Early Pregnancy Failure. Obstet Gynecol. 2006;107(4):901–7.[6] Barceló F, De Paco C, López-Espín JJ, Silva Y, Abad L, Parrilla JJ. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol. Aust New Zeal J Obstet Gynaecol. 2012;52(1):39–43.[7] Committee on Practice Bulletins—Gynecology. Early Pregnancy Loss. Am Coll Obstet Gynecol [Internet]. 2015; number 150. Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Practice- Bulletins/Committee-on-Practice-Bulletins-Gynecology/Early-Pregnancy-Loss[8] Hasan R, Baird DD, Herring AH, Olshan AF, Jonsson Funk ML, Hartmann KE. Association between first- trimester vaginal bleeding and miscarriage. Obstet Gynecol. 2009;114(4):860–7.[9] Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynecol Obstet. 2007;99:172–7.[10] Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004;19(2):266–71.[11] INVIMA. Mifepristona [Internet]. Expediente 20104433. 2016. Available from: http://consultaregistro.invima.gov.co:8082/Consultas/consultas/consreg_encabcum.jsp[12] von Hertzen H, Piaggio G, Huong NTM, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet. 2007;369(9577):1938–46.[13] Tang OS, Ho PC. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion. Contraception. 2006;74(1):26–30.[14] Committee on Practice Bulletins—Gynecology and the Society of Family Planning. Medical management of first-trimester abortion. Am Coll Obstet Gynecol. 2014;89(3):148–161.[15] Tang J, Kapp N, Dragoman M, De Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynecol Obstet [Internet]. 2013;121(2):186–9. Available from: http://dx.doi.org/10.1016/j.ijgo.2012.12.009[16] Jp N, Gml G, Hickey M, Jc V, Dou L. Medical treatments for incomplete miscarriage (Review). Cochrane Libr. 2013;(3).[17] Gómez-Sánchez P. Manual FLASOG uso Misoprostol en Ginecoobstetricia. 2013.[18] INVIMA. Acta 20, Radicado 7023192. Minist Salud y Protección Soc. 2007.[19] Corte Constitucional. Sentencia C-355/06 [Internet]. República de Colombia. 2006. Available from: http://www.corteconstitucional.gov.co/relatoria/2006/c-355-06.htm[20] INVIMA. Decreto No. 4444. 2005.[21] Colombia Ministerio de la Protección Social. Resolución 4905 [Internet]. 2006. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución 4905 de 2006.PDF[22] Blanchard K, Shochet T, Coyaji K, Nguyen Thi NN, Winikoff B. Misoprostol alone for early abortion: An evaluation of seven potential regimens. Contraception. 2005;72(2):91–7.[23] Gemzell-Danielsson K, Bygdeman M, Aronsson A. Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006;74(1):31–5.[24] Gemzell-Danielsson, L Marions, A Rodriguez, BW Spur, PYK Wong MB. Comparison Between Oral and Vaginal Administration of Misoprostol on Uterine Contractility. Am Coll Obstet Gynecol Elsevier. 1999;93(2):275–80.[25] Granstrom G, Granstrom M, Anderson M. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone mifepristone and an exogenous prostaglandin given. Lancet. 1991;338:1233–6.[26] Odeh M, Tendler R, Kais M, Maximovsky O, Ophir E, Bornstein J. Early pregnancy failure: Factors affecting successful medical treatment. Isr Med Assoc J. 2010;12(6):325–8.[27] Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, et al. Outcome of first trimester medical termination of pregnancy: definitions and management. Eur J Contracept Reprod Heal Care [Internet]. 2018;23(6):451–7. Available from: https://doi.org/10.1080/13625187.2018.1535058[28] Chung T, Leung P, Cheung L, Haines C, Chang A. A medical approach to management of spontaneous abortion using misoprostol. Acta Obstet Gynecol Scand. 1997;76:248–51.[29] Cheung LP, Haines CJ, Chang AMZ. Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril. 1999;71(6):1054–9.[30] Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception [Internet]. 2016;94(2):97–103. Available from: http://dx.doi.org/10.1016/j.contraception.2016.04.013[31] Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynecol Obstet. 2017;138(3):363–6.[32] Berghella V, Airoldi J, O’Neill A, Einhorn K, Hoffman M. Misoprostol for second trimester pregnancy termination in women with prior caesarean: A systematic review. BJOG An Int J Obstet Gynaecol. 2009;116(9):1151–7.[33] Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: A systematic review. Am Coll Obstet Gynecol. 2009;113(5):1117–23.[34] Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Westhoff C, et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. Am J Obstet Gynecol. 2008;198(6):626.e1-626.e5.[35] Memtsa M, Jauniaux E, Gulbis B, Nyrhinen NC, Jurkovic D. Maternal serum markers in predicting successful outcome in expectant management of missed miscarriage. Reprod Biomed Online, Elsevier [Internet]. 2017;34(1):98–103. Available from: http://dx.doi.org/10.1016/j.rbmo.2016.09.004http://creativecommons.org/licenses/by-nc-nd/2.5/co/Abierto (Texto Completo)Atribución-NoComercial-SinDerivadas 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2Rueda, S. (2021). Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectiva. Recuperado de: http://hdl.handle.net/20.500.12749/20369.Factores asociados al éxito del manejo médico con misoprostol en el aborto espontáneo: una cohorte prospectivaFactors associated with the success of medical management with misoprostol in spontaneous abortion: a prospective cohortConferenceinfo:eu-repo/semantics/conferenceProceedingsMemoria de eventoshttp://purl.org/coar/resource_type/c_f744info:eu-repo/semantics/acceptedVersionhttp://purl.org/redcol/resource_type/EC_ACUniversidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludSistema de Investigación SIUNABGynecologyObstetricsAbortionInvestigationMisoprostolMaternal mortalityPregnancyWomenGinecologíaObstetriciaAbortoInvestigaciónMisoprostolMortalidad maternaEmbarazoMujeresORIGINAL2021_Articulo_Rueda_Espinel_Santiago.pdf2021_Articulo_Rueda_Espinel_Santiago.pdfArtículoapplication/pdf320016https://repository.unab.edu.co/bitstream/20.500.12749/20369/1/2021_Articulo_Rueda_Espinel_Santiago.pdfe86a5908412ff9c7377ad6dcc926afe8MD51open accessLICENSElicense.txtlicense.txttext/plain; charset=utf-8829https://repository.unab.edu.co/bitstream/20.500.12749/20369/2/license.txt3755c0cfdb77e29f2b9125d7a45dd316MD52open accessTHUMBNAIL2021_Articulo_Rueda_Espinel_Santiago.pdf.jpg2021_Articulo_Rueda_Espinel_Santiago.pdf.jpgIM Thumbnailimage/jpeg9712https://repository.unab.edu.co/bitstream/20.500.12749/20369/3/2021_Articulo_Rueda_Espinel_Santiago.pdf.jpg8b393d30c42f219fade49dfcf64d4d41MD53open access20.500.12749/20369oai:repository.unab.edu.co:20.500.12749/203692023-06-28 22:00:23.899open accessRepositorio Institucional | Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.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

Publicaciones similares